March 30, 2009 - Beaumont Hospitals, based in Royal Oak, MI, will be expanding its current IMPAX radiology PACS (Picture Archiving and Communication System) to include IMPAX Cardiovascular for imaging and reporting in its cardiology department.

March 30, 2009 - The FDA and Watson Pharmaceuticals notified healthcare professionals and patients of a recall of cardiac arrhythmias drug Propafenone HCL 225 mg tablets because some tablets may contain slightly higher levels of the active ingredient than specified.

March 30, 2009 - GE Healthcare and Archimedes Inc., an independent Healthcare Modeling organization, announced at ACC that they will collaborate to launch a new virtual study to identify an enhanced diagnostic protocol for predicting coronary heart disease (CHD).

March 30, 2009 – Lantheus Medical Imaging Inc. released at ACC 2009 new data regarding the use of DEFINITY Vial For (Perflutren Lipid Microsphere) Injectable Suspension that finds significant survival benefit for critically ill patients undergoing contrast-enhanced echocardiography.

March 30, 2009 – Analysis of Boston Scientific’s SYNTAX trial found that while the overall cost effectiveness of percutaneous coronary intervention (PCI) versus coronary artery bypass graft (CABG) surgery varied according to patient characteristics, PCI was more cost effective than CABG in patients with low or moderate coronary lesion complexity.

March 30, 2009 - Twelve-month data from the high-risk registry arm of the EVEREST II study shows that percutaneous mitral valve repair using the MitraClip system in symptomatic high-risk surgical patients with functional mitral regurgitation (FMR) improves patient clinical status and left ventricular function.